A commonly used tuberculosis vaccine may help prevent coronavirus infections or reduce the severity of the virus, the Los Angeles Daily News reports.

Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more

Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens

   

According to a new study by Cedars-Sinai, the Bacillus Calmette-Guérin vaccine, also known as BCG vaccine, could play a role in reducing the chances of contracting the virus.

The BCG vaccine was developed in the early 1900s. It is approved by the U.S. Food and Drug Administration and given to 100 million children annually across the world.

According to the outlet, the vaccine is FDA-approved to treat bladder cancer and also given to people at high risk of catching TB. It is currently being tested in several clinical trials for its effectiveness against COVID-19.

A new study published in The Journal of Clinical Investigation studied the blood of more than 6,000 healthcare workers in the Cedars-Sinai Health System for evidence of antibodies to the coronavirus.

Read more at NEWSMAX.